Dipeptidyl peptidase IV and adenosine deaminase activity: Decrease in depression
- 30 November 1999
- journal article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 24 (8) , 823-832
- https://doi.org/10.1016/s0306-4530(99)00039-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated CleavageThe Journal of Experimental Medicine, 1997
- Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remissionArchiv Fur Psychiatrie Und Nervenkrankheiten, 1997
- Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: Relationships with immune-inflammatory markersPsychoneuroendocrinology, 1997
- Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugsActa Psychiatrica Scandinavica, 1996
- Binding of adenosine deaminase to the lymphocyte surface via CD26European Journal of Immunology, 1994
- Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequencesFEBS Letters, 1993
- Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26Science, 1993
- Autoimmunity in depression: increased antiphospholipid autoantibodiesActa Psychiatrica Scandinavica, 1993
- Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illnessPublished by Elsevier ,1992
- A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patientsPsychological Medicine, 1991